Ubiquitin activation is essential for schizont maturation in Plasmodium falciparum blood-stage developmentMore about Open Access at the Crick
Authors listJudith Green Yang Wu Vesela Encheva Edwin Lasonder Adchara Prommaban Simone Kunzelmann Evangelos Christodoulou Munira Grainger Ngoc Truongvan Sebastian Bothe Vikram Sharma Wei Song Irene Pinzuti Chairat Uthaipibull Somdet Srichairatanakool Veronique Birault Gordon Langsley Hermann Schindelin Benjamin Stieglitz Bram Snijders Tony Holder
Ubiquitylation is a common post translational modification of eukaryotic proteins and in the human malaria parasite, Plasmodium falciparum (Pf) overall ubiquitylation increases in the transition from intracellular schizont to extracellular merozoite stages in the asexual blood stage cycle. Here, we identify specific ubiquitylation sites of protein substrates in three intraerythrocytic parasite stages and extracellular merozoites; a total of 1464 sites in 546 proteins were identified (data available via ProteomeXchange with identifier PXD014998). 469 ubiquitylated proteins were identified in merozoites compared with only 160 in the preceding intracellular schizont stage, suggesting a large increase in protein ubiquitylation associated with merozoite maturation. Following merozoite invasion of erythrocytes, few ubiquitylated proteins were detected in the first intracellular ring stage but as parasites matured through trophozoite to schizont stages the apparent extent of ubiquitylation increased. We identified commonly used ubiquitylation motifs and groups of ubiquitylated proteins in specific areas of cellular function, for example merozoite pellicle proteins involved in erythrocyte invasion, exported proteins, and histones. To investigate the importance of ubiquitylation we screened ubiquitin pathway inhibitors in a parasite growth assay and identified the ubiquitin activating enzyme (UBA1 or E1) inhibitor MLN7243 (TAK-243) to be particularly effective. This small molecule was shown to be a potent inhibitor of recombinant PfUBA1, and a structural homology model of MLN7243 bound to the parasite enzyme highlights avenues for the development of P. falciparum specific inhibitors. We created a genetically modified parasite with a rapamycin-inducible functional deletion of uba1; addition of either MLN7243 or rapamycin to the recombinant parasite line resulted in the same phenotype, with parasite development blocked at the schizont stage. Nuclear division and formation of intracellular structures was interrupted. These results indicate that the intracellular target of MLN7243 is UBA1, and this activity is essential for the final differentiation of schizonts to merozoites.
Journal PLOS Pathogens
Issue number 6
Discovery with a purpose - to improve people's health and wellbeing - is central to the Crick.
We conduct discovery science, aimed at solving human health challenges. Our translation and innovation strategy seeks to turn this science into improvements in the lives of people around the world, as well as generating economic opportunities.
We aim to improve lives by identifying possible therapies, diagnosis and disease prevention. This often offers opportunities to form new businesses and grow existing ones, creating highly skilled employment and the potential for other activities that reinforce the UK's position at the forefront of innovation in life sciences.
To realise these health benefits, we have created an environment where basic and clinical scientists can work together closely and effectively.
We don’t carry out patient-based research at The Crick, but we use the clinical and regulatory expertise of our three university founders, their Academic Health Science Centres (AHSCs) and National Institute for Health Research (NIHR) and Biomedical Research Centres (BRCs).
These close working relationships helps in the development of experimental medicine, a key element of translational research.